3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Pancreatic Neoplasms
1
Hematologic Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Cachexia
1
Adenocarcinoma
1
Interventions
Megestrol Acetate
6
Standard of Care
3
Exercise
3
Physical Therapy Modalities
2
Nutrition Assessment
2
Infliximab
2
Blood Specimen Collection
2
testosterone enanthate
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
irinotecan sucrosofate
1
clazakizumab
1
bermekimab
1
anamorelin
1
Sodium Chloride
1
Radiotherapy
1
Preoperative Exercise
1
Powders
1
Pentoxifylline
1
Olanzapine
1
Nandrolone Decanoate
1
Mirtazapine
1
Melatonin
1
Megestrol
1
Immunologic Techniques
1
Ibuprofen
1
High-Energy Shock Waves
1
Ghrelin
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cachexia
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled